ISA101b
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for ISA101b, covering 2019-03-06 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy [Phase 2]